Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation. | Cell Commun Signal | 2024 | 38233853 | PubTator, text mining | PubMed |
| Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance. | Heliyon | 2024 | 38226210 | PubTator, text mining | PubMed |
| AGO2-RIP-Seq reveals miR-34/miR-449 cluster targetome in sinonasal cancers. | PLoS One | 2024 | 38215077 | PubTator, text mining | PubMed |
| Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond. | Clin Kidney J | 2024 | 38213493 | PubTator, text mining | PubMed |
| Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer. | Cell Mol Life Sci | 2024 | 38212428 | PubTator, text mining | PubMed |
| Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice. | Sci Rep | 2024 | 38195835 | PubTator, text mining | PubMed |
| Association of MST1 in the First Trimester of Pregnancy with Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes. | Diabetes Metab Syndr Obes | 2024 | 38192496 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Insight into the function of tetranectin in human diseases: A review and prospects for tetranectin-targeted disease treatment. | Heliyon | 2024 | 38187250 | PubTator, text mining | PubMed |
| Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause. | Commun Biol | 2024 | 38184718 | PubTator, text mining | PubMed |
Synchronous Epidermodysplasia Verruciformis and Intraepithelial Lesion of the Vulva Is Caused by Coinfection With Alpha-Human Papillomavirus and Beta-Human Papillomavirus Genotypes and Facilitated by Mutations in Cell-Mediated Immunity Genes. | Arch Pathol Lab Med | 2024 | 38180082 | PubTator, text mining | PubMed |
| Multiple Origins of Bioluminescence in Beetles and Evolution of Luciferase Function. | Mol Biol Evol | 2024 | 38174583 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential. | J Cancer | 2024 | 38169510 | PubTator, text mining | PubMed |
| Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38169461 | PubTator, text mining | PubMed |
| Innate immune and proinflammatory signals activate the Hippo pathway via a Tak1-STRIPAK-Tao axis. | Nat Commun | 2024 | 38168080 | PubTator, text mining | PubMed |
| IGFBP5, as a Prognostic Indicator Promotes Tumor Progression and Correlates with Immune Microenvironment in Glioma. | J Cancer | 2024 | 38164271 | PubTator, text mining | PubMed |
| The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention. | Int J Biol Sci | 2024 | 38164186 | PubTator, text mining | PubMed |
| Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. | Int J Biol Sci | 2024 | 38164167 | PubTator, text mining | PubMed |
| GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. | Biol Direct | 2024 | 38163861 | PubTator, text mining | PubMed |
| Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3. | J Med Chem | 2024 | 38126712 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=12